Crescita Therapeutics Inc. (TSE:CTX – Get Free Report) was up 3.7% during trading on Tuesday . The stock traded as high as C$0.56 and last traded at C$0.56. Approximately 10,000 shares changed hands during trading, a decline of 54% from the average daily volume of 21,969 shares. The stock had previously closed at C$0.54.
Crescita Therapeutics Price Performance
The business has a 50-day moving average price of C$0.58 and a two-hundred day moving average price of C$0.57. The company has a quick ratio of 2.29, a current ratio of 3.37 and a debt-to-equity ratio of 6.02. The company has a market capitalization of C$11.24 million, a price-to-earnings ratio of -3.87 and a beta of 1.69.
Crescita Therapeutics Company Profile
Crescita Therapeutics Inc, a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers (MMPE) and DuraPeel for the development of topicals containing cannabis and hemp.
Featured Stories
- Five stocks we like better than Crescita Therapeutics
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Micron Stock Under $100: Seize the AI-Driven Upside
- Stock Market Sectors: What Are They and How Many Are There?
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- What Are the FAANG Stocks and Are They Good Investments?
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for Crescita Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescita Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
